• Register Your Study
  •  Login
  • Home
  • EQ-5D
  • EuroQol Group
  • News
  • Contact
  • Home
  • EQ-5D
  • What is EQ-5D?
  • Who is using EQ-5D
  • What is EQ-5D?
    • How to use EQ-5D
    • Who is using EQ-5D
    • How to report
    • EQ-5D nomenclature
  • EQ-5D products
  • How to obtain EQ-5D
  • Valuation of EQ-5D
  • Population norms
  • Proceedings search
  • Reference search
  • Publications
  • FAQs

Who is using EQ-5D

EQ-5D inclusion in national guidelines

There is now an increasing demand for EQ-5D usage in clinical and economic evaluation of health care as well as in population health surveys. Furthermore, EQ-5D is one of a handful of measures recommended for use in cost-effectiveness analyses by the Washington Panel on Cost Effectiveness in Health & Medicine. In the UK, The National Institute for Clinical Excellence (NICE) has issued revised guidance that argues for the use of measures like EQ-5D that have been weighted according to the social preferences of the UK population. Also a NHS Task Group (UK) has been set up to co-ordinate the testing of EQ-5D as an outcome measure for use by clinicians and managers. The EuroQol Group advises anyone thinking of using EQ-5D to contact one of the members of the Group (preferably in the country where the research is being conducted) if specific details about the application of EQ-5D are required. The EuroQol Executive Office can be contacted to act as an intermediary if necessary.

Which researchers are using EQ-5D?

Multi-national users: At an international level, the pharmaceutical industry and scientific groups are the foremost users of the instrument. EQ-5D is being applied in multinational trials by pharmaceutical companies. Since EQ-5D is available in many languages in a standardised format, it can potentially be used to translate differences in outcome across borders.

National users: At a national level, the institutions involved are country-specific and the use of EQ-5D in the demand and supply areas of health care is widespread. The following list gives some idea of those involved:

  • General Practitioners
  • Hospital Specialists
  • Nurses and Remedial Therapists
  • Researchers into clinical practice
  • Those responsible for audit and quality assurance
  • Public Health Specialists
  • Health service Researchers
  • Managers in Health Care Institutions


For which purpose?

Below are some of the more specific ways in which EQ-5D is being used:

  • Monitoring the health status of patient groups at different moments in time, e.g. referral, admission, discharge, follow-up of outpatients.
  • Evaluation and audit of health care, by measuring changes in health status in individual patients and in groups of patients.
  • Assessing the seriousness of conditions at different moments in time.
  • Providing relevant information for resource allocation at a variety of levels.
  • Assisting in providing evidence about medical effectiveness in processes where drugs or procedures have to be approved.
  • Establishing levels of population health status both locally and nationally. Examples include health surveys carried out in Canada, Finland, Spain (1994 Catalan health survey interview) and the UK (UK Department of Health Omnibus Sample Survey 1996, Health Survey for England). and the US (current Medical Expenditure Panel Survey by the Agency for Healthcare Research and Quality). 


In which countries is EQ-5D being used?

taartdiagram

In what type of study is EQ-5D used?

taartdiagram

Examples of clinical areas where EQ-5D is used:

Acne
Acupuncture
Alcohol dependency
Angioplasty
Angina (treatment options)
Anorectal reconstruction
Asthma
Blood transfusion
Bone marrow transplant
Breast cancer
Breast cancer screening
Bronchitis
Cardiac surgery
Cardiology
Cardiovascular disease
Cataract surgery
Chemotherapy (impact)
Chronic fatigue
Chronic illness
Cochlear implantation
Colles fracture
Colorectal carcinoma
Congestive heart failure
Conservation work (benefits of)
Cosmetic surgery
Cystic fibrosis
Dementia
Detoxification
Diabetes
Drug monitoring (nursing home residents)

Dyspepsia
Dystonia
Elderly (QOL)
Endometriosis
Enteral nutrition
Epilepsy
Erectile dysfunction
Fabry’s disease
Gastro-enteritis
General practice
Geriatrics
Gilles de la Tourette
Graves eye disease
Growth Hormone
Haemophilia
Hip fracture/replacement
HIV infection
Hodgkin’s dis.
Homeopathy
Hormone replacement therapy
Hospital waiting lists
Hysterectomy
Imperforate anus
Inguinal hernia
Incontinence
Intensive care
Intestinal failure
Ischaemic heart disease
Joint replacement
Leg ulcer clinics
Liver disease
Liver transplantation

Low back pain
Lung cancer
Lung embolism
Lung transplantation
Lymphoedema
Magnetic Resonance Imaging
Melanoma (stage III)
Menorrhagia
Migraine
Multiple Sclerosis
Myeloid Leukaemia
Myocardial infarction
Neonatal surgery
Neural tube defects
Neurosurgery
Non-Hodgkin’s disease
Lupus
Lymphoma
Nutrition
Obstructive sleep apnoea
Orthopaedic medicine
Osteoarthritis
Pain
Pancreatic cancer
Parenteral nutrition
Peripheral arterial disease
Peripheral vascular disease
Physiotherapy
Picture archiving and Communication systems (PACS)

Population health surveys
Primary care
Prostatic hypertrophy
Prostate cancer
Psoriasis
Psychiatric problems in GP practice
Redundancy (impact of)
Rehabilitation (effects of)
Renal disease (end-stage)
Renal oncology
Renal (kidney stone disease)
Respiratory illness
Rheumatoid arthritis
Rhinitis
Road accidents (non-fatal)
Schizophrenia
Sepsis
Sinusitis
Smoking (impact of)
Stent
Stroke Trauma
Tuberculosis (prevention in HIV)
Turner’s syndrome
Urology
Vascular surgery
Venous leg ulcers
Visual impairment
Weight loss (treatment for)
Women’s surgery

CONTACT US | DISCLAIMER | SITEMAP

Copyright Notice
All content ©  EuroQol Group | TYPO3 door Redkiwi